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ABSTRACT
The main objective of this study was to retrospectively report our institutional
outcomes with the long-term management of neurogenic bladder in spinal cord injury
patients. Specifically to: (A) report the association of recurrent urinary tract infection
(UTI) with the long-term use of clean intermittent catheterization (CIC) in our population
of spinal cord injury (SCI) patients. (B) Secondly, to evaluate the use of retroperitoneal
ultrasound for long-term renal tract surveillance in injured patients. (C) And thirdly, to
describe our experience with the use of the lowsley retractor method for suprapubic
cystostmy in patients with neurogenic bladder.
Subjects were selected from patients followed by one physician at the Yale
Urology Medical Group and their medical records were retrospectively reviewed. To
address objectives (A) and (B), patients were identified after a search of the Financial
Department’s database with diagnosis codes for “neurgenic bladder” and “Spinal cord
injury.” Patients seen between the years 2000 to 2010 were included in the study. For
objective (C), patients were identified with diagnosis code for “cystostomy” and patients
seen between 1995 and 2010 were included in the study.
For objective (A), 51 male and 10 female subjects were managed with CIC. 41
(67%) subjects were placed on medical prophylaxis (PRx) for symptomatic recurrent
UTI. 28 (72%) subjects were started on PRx within 2 years after initiation of CIC. 48 SCI
patients were included in objective (B). Mean follow-up was 6.8 years. By final followup 7 (15%) subjects had moderate/minimal hydronephrosis. 4 (8%) cases were new
compared to initial assessment. No severe cases of hydronephrosis were noted. For
objective (C), 49 primary catheter placements were performed on 44 patients. Operation-

time documented in 19 (39%) cases was 20.2 min (5.5) (range: 11-31 min). Blood loss
was minimal and there were no intra-operative complications or cases of incorrect
catheter placements.
The improved life expectancy of SCI patients in recent decades makes long-term
complications of neurogenic bladder management more pertinent. Although CIC is the
current standard of care following SCI, recurrent UTI remains a major complication in
patients using this technique. Due to a lack of standard guidelines for long-term renal
tract monitoring in injured patients, there is wide variation in surveillance strategies. Our
results suggest that annual retroperitoneal ultrasound is effective for renal tract
monitoring rather than subjecting patients to annual urodynamic testing. Furthermore, the
improved anticholinergic therapy makes suprapubic catheters an acceptable alternative to
intermittent catheterization. Our findings support the use of the lowsley retractor method
of suprapubic catheter placement as a safe and effective method for isolated suprapubic
cystostomy in neurogenic bladder patients.
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-1INTRODUCTION
Renal disease resulting from neurogenic voiding dysfunction has historically been
the leading cause of death in individuals with spinal cord injury (SCI). The decision to
create special spinal injury units within selected hospitals during the Second World War
prompted the modern era of treatment of spinal cord injured persons [1]. These regional
specialized treatment units played an important role in studying and better understanding
the needs of injured patients [2]. Subsequent advances in urologic management are
credited for the improved survival in this patient population [3] and life-long urologic
follow-up is critical to maintain quality of life and minimize urinary tract associated
morbidity. The improved life expectancy in SCI patients attained by these advances in
urologic care makes long-term complications of the urinary tract more pertinent,
therefore mandating continued research related to urinary tract dysfunction.

The Neurogenic Bladder in Spinal Cord Injury
Neurogenic bladder (NGB) is broadly defined as the abnormal function of the
urinary bladder secondary to any neurologic condition of the central nervous system or
the peripheral nerves involved in the control of micturition [4]. Such neurologic
conditions include spinal cord injury (SCI), neural tube defects, multiple sclerosis (MS),
brain tumors as well as other diseases of peripheral nerves. In order to minimize the
variability in subjects, this work specifically focuses on cases of neurogenic bladder
caused by traumatic spinal cord injury.
It is estimated that about 12,000 new cases of spinal cord injury occur in the
United States each year, with an estimated prevalence of 262,000 persons in the year

-22009 [5]. Alteration in the function of the lower urinary tract is one of the most
problematic consequences of spinal cord lesions resulting in urologic complications
following SCI. Although the mortality related to such complications has been
significantly reduced in recent decades [6], urinary tract problems remain a prominent
cause of morbidity [7]. These problems account for the majority of hospital readmissions
following SCI [8] and necessitate life-long urologic follow up as a central component in
the routine care of injured patients.
The effect of spinal cord injury on the urethral sphincter and on the function of
the detrusor muscle is the cause of neurogenic bladder dysfunction [9]. The degree of
damage to the voiding cycle depends on the location, completeness as well as the
vascular extension of the injury. A model of supraspinal bladder control is suggested by
brain imaging studies. According to this model afferent signals from the lower urinary
tract are received in the periaqueductal gray and relayed via the thalamus to the insula
(which makes sensations accessible to conscious awareness). The cortex (via the anterior
cingulate gyrus) monitors and controls micturition reflexes and also makes voluntary
voiding decisions (via the prefrontal cortex) [10].
The normal micturition reflex is thought to be mediated by an area of the pons
known as the pontine micturition center (PMC) or Barrington nucleus. This region
coordinates the activity of the detrusor and urethral sphincter muscles [11, 12, 13]. The
tip of spinal cord is located in the L1/L2 level of the vertebrae, however the detrusor
muscle of the bladder and the internal urethral sphincter are innervated by
parasympathetic sacral nerve roots (S2-S4) via the pelvic splanchnic nerve, in addition to
some sympathetic innervation by T10-L2 nerve roots via the hypogastric nerve. On the

-3other hand, the external urethral sphincter is innervated by somatic sacral nerve roots (S2S4) via the pudendal nerve. Injuries to the lumbar spine can destroy the conus of the cord
or the cauda equina resulting in the loss of sacral reflexes. The loss of sacral reflex
activity will produce detrusor areflexia (DA), and flaccid paraplegia. Since injuries to the
cervical and thoracic regions of the cord occur above the conus they typically cause
detrusor hyperactivity (DH) and detrusor external sphincter dyssynergia (DESD), which
describes the contraction of the bladder against a closed external sphincter. Quadriplegia
may be observed if a complete cervical injury occurs.
The urologic function following SCI is generally categorized into three phases:
(1) spinal shock, (2) recovery, and (3) stable phases [14]. Immediately following the
initial injury, the swelling of the spinal cord fills the spinal canal and prevents
oxygenation and blood flow to the spinal cord tissue. This precipitates spinal shock,
which involves a temporary loss of function in the undamaged areas of the spinal cord
causing the inhibition of all reflexes and function distal to the level of injury and resulting
in a flaccid detrusor [15]. The recovery phase refers to the return of reflex activity and
marks the end of spinal shock. Following the recovery phase, a fairly stable urodynamic
picture is observed, this marks the stable phase and it represents the period when there are
no further signs of neurologic recovery.

Bladder Management with Catheterization
Various modalities are employed in the management of neurogenic bladders after
the stable phase is reached. Common catheterization methods include the use of clean
intermittent catheters, indwelling urethral catheters, or indwelling suprapubic catheters.
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involves the passage of a clean (non-sterile) straight catheter through the urethra to empty
the bladder. Catheterization is typically done about 4 to 6 times daily. Indwelling
urethral catheterization involves leaving a trans-urethral foley catheter in the bladder,
secured by a balloon, with a drainage bag attached usually to the thigh. The catheter is
typically replaced every 3 to 4 weeks. An indwelling suprapubic catheter involves the
creation of a surgical vesicostomy through the lower abdominal wall to allow a catheter
to be placed into the bladder suprapubically. The tube is also replaced every 3 to 4 weeks.
Individuals managed with long-term urinary catheters are at risk for many serious
complications including: urethral complications such as the formation of strictures and
false passages, chronic obstruction due to urinary calculi and periurethral infections
including epididymitis and prostatitis. Other associated complications include life
threatening complications such as pyelonephritis and bladder cancer.
The optimal catheterization method for managing the neurogenic bladder remains
controversial because no randomized studies have been done to determine which method
of catheterization is superior in the long-term management of spinal cord injured patients.
Many studies addressing this topic have reached different conclusions. In a comparative
study of 80 patients in Karachi Pakistan, Turi and colleagues found intermittent
catheterization to be superior to indwelling catheterization with respect to complications
and infections rates [17]. And a retrospective study of 316 posttraumatic spinal cord
injured patients with a mean follow-up of 18 years concluded that CIC is the safest
method of bladder management with respect to urological complications [18]. On the
other hand, a comparative study in Helsinki, Finland, by Dahberg and associates found a
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with intermittent catheterization [19]. Other studies have not found significant differences
in the incidence of urological complications between spinal cord injury patients managed
with or without a bladder catheter [20].
The most recent Cochrane review addressing this issue included about 400
studies comparing these methods and found no evidence from randomized or quasirandomized controlled trials to draw any conclusions about the use of catheters [21]. The
panel of experts at the Infectious Diseases Society of America (IDSA) similarly
determined, in 2009, that there was insufficient evidence to recommend whether:
suprapubic catheterization was superior to indwelling urethral catheterization or whether
intermittent catheterization is superior to supra-pubic catheterization for reduction of
catheter associated urinary tract infection (UTI) [22].
Regardless of the lack of randomized controlled trial to determine the superior
catheterization method, clean intermittent catheterization is popularly believed to be
associated with fewer complications compared with indwelling catheters and it is widely
accepted as the preferred method of bladder management. Hill and Davies, in 1988,
proposed the use of self intermittent catheterization as the preferred bladder management
method in all spinally injured patients with good hand function [23]. This technique was
recommended by the international consortium on incontinence, in 2010, as the first
choice for individuals that are unable to empty their bladder adequately and safely [24].

A Second Line in Bladder Management
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neurogenic bladder management in appropriate patients usually after failed CIC or severe
urethral damage [25]. A recent review on the role of SPC in treatment of NGB suggests
that although early reports of long-term renal and bladder complications discouraged its
use for long-term NGB management, current improved pharmacotherapy with anticholinergics and better bladder maintenance strategies may have improved its efficacy
[26]. Sheriff et al. reported that 82% of patients with long-term suprapubic catheters
indicated that it positively improved their quality of life [25]. The placement of
suprapubic catheters in NGB patients is often done as an isolated procedure and is
thought to have a low associated risk. However, the risk of intra-operative and postoperative complications has been demonstrated to be higher in patients with NGB
compared to those with other lower urinary tract dysfunction. Ahluwalia et al. reported a
34% overall complication rate in NGB patients compared to 18% in patients with other
forms of bladder outflow obstruction (P = 0.057) and recommended that such high-risk
cases be performed in a controlled environment with senior surgeon and anesthesia
present [27].
Suprapubic catheter placement can be done with an open technique or by using
one of the various percutaneous or other minimally invasive methods [28]. Each
approach has its limitations; the open technique is considered the definitive gold-standard
but it requires a larger incision, with potentially longer operative time, and more blood
loss [29]. The risk of complication using blind percutaneous technique is low but such
complication can be fatal. Such risks include through and through puncture of the bladder
and potential injury to the bowel [30]. Ahluwalia et al. described a 2.5% risk of bowel
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of SPC under cystoscopic guidance. The imaging guided technique was introduced to
reduce the risks associated with the percutaneous approach [31]. Cronin and colleagues
recently reported their experience with the imaging-guided approach in a review of SPC
performed on 549 patients by skilled interventional radiologists using either the trocar or
seldinger technique [32]. Their procedures involved transurethral distention of the
bladder with contrast material and imaging-guided cystostomy using a combination of
ultrasound and fluoroscopy. The use of ultrasonography however is limited by the skill of
the practitioner and a disadvantage of fluoroscopy is the risks associated with exposing
patients to ionizing radiation.

Long-Term Complications
SCI patients suffer from various degrees of detrusor dysfunction, including
hyperreflexia, areflexia, detrusor sphincter dyssynergia, poor compliance and chronic
urinary tract infection. Urodynamic testing is thought to be the most important predictor
of the urologic outcome [33]. This test measures the pressure in the bladder and the
electrical activity of the urethral sphincter to determine the effects of the neurological
injury. It is used to define the type of neurogenic dysfunction and for planning the
bladder management strategy. The findings of urodynamic testing after the patient is
beyond the spinal-shock phase should determine the long-term bladder management
strategy [14].
Amongst the most common urologic manifestations of neurogenic voiding
dysfunction is the problem of recurring UTIs. The vast majority of UTIs are caused by
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gram-negative bacilli and enterococci [7]. Factors contributing to risk of UTI in persons
with SCI include incomplete emptying of the bladder, low bladder wall compliance and
insertion of urinary catheters.
Due to the widespread use of urinary catheterization, bacteriuria associated with
the use of catheters is the most common healthcare-assocaited infection worldwide [22].
Long-term indwelling urinary catheterization inevitably results in lower urinary tract
colonization. Significant levels of bacteria can be seen in the urine of patients managed
by an indwelling catheter within 72 hours of insertion, and levels of bacteria increase 5%
to 8% per day [34]. In comparison, while the likelihood of chronic bacteriuria is also
increased by CIC, it is believed that this risk is offset by the benefit of not having the
continued presence of a foreign object in the lower urinary tract.
There is an important distinction between asymptomatic bacteriuria and
symptomatic urinary tract infections. Most neurogenic bladder patients will have
bacteriuria yet they remain free from symptoms associated with a UTI and can be
described as having “asymptomatic bacteriuria.” An immune response triggered by
bacterial invasion of the bladder wall causes the symptoms of “clinical UTI [35].” While
an increased risk of symptomatic UTI is associated with asymptomatic bacteriuria, the
use of antibiotics is not indicated unless UTI symptoms develop [15].
The routine use of antimicrobial prophylaxis remains controversial due to many
conflicting results from studies looking at its efficacy in preventing infections. A metaanalysis of 15 controlled trials did not find a significant reduction in symptomatic
infections when prophylactic antimicrobials were administered, rather, the use of
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organisms [36]. Routine cultures in healthy asymptomatic patients are similarly
discouraged since the practice causes an unnecessary treatment of bacteriuria [37].
Beyond urinary tract infections, renal deterioration is a fatal long-term
consequence of poor bladder management. The goal of urologic management in SCI is to
prevent upper tract deterioration and maintain continence. Renal deterioration leading to
renal failure is principally caused by vesicoureteral reflux, chronic pyelonephritis, renal
stone formation and hydronephrosis [38]. Normal bladder function requires urine storage
at low intravesical pressure without leakage. Therefore, efforts to preserve adequate
urinary tract function must maintain adequate detrusor pressures.
McGuire and colleagues in 1983 determined that high detrusor leak point
pressure was related to upper tract deterioration [39]. Outlet obstruction associated with
detrusor leak point pressure greater than 40 cm is now considered the major risk factor
for upper tract deterioration [40, 41]. It is explained that an elevated urethral resistance
causes deterioration in compliance that results in an increased detrusor pressure (Pdet).
The increased Pdet is transmitted to the ureter consequently increasing the ureteral work
until it reaches a limit at about 40 cm of water. At this point the delivery of urine from the
ureter to the bladder ceases. It is therefore believed that the effects on the ureter seen by
imaging are late rather than immediate changes of lower tract dysfunction [42].

Urinary Tract Surveillance
There are no standard guidelines established to routinely monitor the urinary tract
in spinal cord injury patients due to the low availability of data relating to the value of
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surveillance strategies in practices around the world [43, 44]. Most urological centers
prefer annual monitoring of upper and lower urinary tract function with either an upper
tract study or a compliance test [45]. The European Association of Urology (EAU)
recommends video-urodynamic investigation every 2 years for patients with normal
bladder compliance who do not have detrusor overactivity. And recommend annual
video-urodynamics for patients with detrusor overactivity and/or low bladder compliance
[46]. Although well tolerated by patients [47], conventional urodynamic testing is
sometimes avoided because it is expensive and carries a risk of urinary tract infection
[48]. Nosseir and colleagues retrospectively investigated the long-term results of 80 SCI
patients managed at their institution with a strictly urodynamic-based treatment regime
and determined that physiologic changes in bladder function can occur in the absence of
changes in overall symptoms thus they recommended annual urodynamic testing in
patients with detrusor overactivity [49]. It is our position that renal tract changes can be
detected on routine ultrasonographic surveillance to obviate the use of regular
urodynamic testing.

Statement of purpose
The primary objective of this investigation was to report outcomes related to the urologic
management of our spinal cord injury patients with neurogenic bladder.
Specifically:
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with the long-term use of clean intermittent catheterization (CIC) for the
management of neurogenic bladder in spinal cord injury (SCI) patients.
b) To report our experience with the lowsley retractor method for suprapubic
cystostomy (SPC) in patients with neurogenic bladder (NGB).
c) To evaluate the efficacy of annual ultrasonography rather than regular
urodynamic testing for upper tract surveillance in spinal cord injury (SCI)
patients managed with long-term intermittent catheterization.
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This study was approved by the institutional review board at Yale University School
of Medicine. Subjects were selected from patients followed by one physician at the Yale
Urology Medical Group and their medical records were retrospectively reviewed. All
patient visits at the urology clinic were logged by the Patient Financial Services
Department under corresponding diagnosis codes and clinic visits or phone calls were
recorded in patient charts by the same physician after each encounter.
a) In order to determine the association of UTI with the long-term use of CIC in our
spinal cord injury patients, the following criteria was employed (Figure 1).
930 patients seen by 1 physician between 2000
and 2010 identified with diagnosis codes for:
“neurogenic bladder” or “spinal cord Injury”
720 Patients Excluded:
 Neurogenic bladder not
caused by spinal cord injury
210 Subjects with neurogenic bladder
caused by spinal cord injury
149 Patients Excluded:
 Had less than 1 yr follow-up
 Had urinary diversion
 Not managed with CIC
61 Subjects met inclusion criteria:
 Neurogenic bladder caused by traumatic SCI
 Managed with clean intermittent catheterization
 At least 1 yr of clinical follow-up

Figure 1: Application of inclusion and exclusion criteria to determine association of
UTIs with the long-term use of CIC. CIC = clean intermittent catheterization; SCI =
spinal cord injury; UTI = urinary tract infection.
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Inclusion criteria: neurogenic bladder dysfunction; stable traumatic spinal cord injury
at least one year after injury; bladder management with clean intermittent
catheterization; minimum of one year follow-up by the same physician at the Yale
Urology Clinic; patient seen between the years 2000 and 2010.
Exclusion criteria: other etiology for neurogenic bladder such as multiple sclerosis,
parkinson’s disease, spina bifida or diabetes; other methods of bladder management
including other catheterization methods, crede maneuver or patients with urinary
diversion.
A list of 930 potential subjects was generated by a search of the Financial
Services records using diagnosis codes for "neurogenic bladder (596.54)" or "Spinal Cord
Injury (952.9)." The search was limited to patients seen by the same physician at the Yale
Urology Medical Group between the years 2000 and 2010. Initial review of the clinical
records eliminated 720 potential subjects who had neurogenic bladder from other
etiology but did not have traumatic spinal cord injury. Of the 210 spinal cord injury
patients with neurogenic bladder, another 149 subjects were excluded either because they
had neurogenic bladder managed by methods other than clean intermittent catheterization
or had undergone urinary diversion. Only 61 traumatic spinal cord injury subjects with
neurogenic bladder managed by intermittent catheterization and followed for at least one
(1) year after spinal cord injury were included in this study (Table 1).

- 14 Table 1. Patient characteristics
Age (y)
43.4 16.3
Sex (n)
Male
51 (84)
Female
10 (16)
Injury level (n)
Cervical
24 (39)
Thoracic
24 (39)
Lumbar
12 (20)
Sacral
1 (2)
Independence (n)
Paraplegic
35 (57)
Tetraplegic
18 (30)
Independent
8 (13)
Duration of catheterization (y)
Before initiating PRx
2.7  3.3
Subjects not requiring PRx
7.2  3.8
Duration of follow-up (y)
5.8 
Use of UTI PRx
Yes
41 (67)
No
20 (33)
Data presented as mean  SD, unless noted
otherwise; data in parentheses are percentages. PRx =
prophylaxis; UTI = urinary tract infection.

Data Gathering
For each research subject the following data points were recorded on Excel:
Age
Gender
Level of spinal injury
Amount of independence
Mean years of follow-up at Yale
Time elapsed since initial injury
Frequency of catheterization
Presence of incontinence
Ultrasound findings
Number of positive urine cultures

Use of UTI prophylaxis
Years after injury before using prophylaxis
Type of UTI prophylaxis
Number of symptomatic UTIs in last year
Number of positive cultures in the year prior
to starting prophylaxis
Urodynamic findings
Pharmacologic control of detrusor
Surgical control of detrusor
Number of symptomatic UTIs in last year

All complications of bladder management were recorded based on the status of subjects
at the time of their last urologic follow-up at Yale.
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Patients experiencing recurrent UTI were identified by their continued use of medical
UTI-prophylaxis (PRx) at the time of last clinical follow-up. Medical PRx in this case is
defined as the use of either oral antibiotics or methenamine with ascorbic acid to decrease
the frequency of UTIs. Subjects were started on PRx when they had experienced ≥ 3
UTIs within a one (1) year period. For subjects on UTI prophylaxis, the recurrent and
symptomatic nature of their infections was verified by the number of positive cultures
occurring within a year prior to starting prophylaxis. Subjects were not placed on PRx if
they have not had at least three episodes of symptomatic UTI within a one year period.
For each subject not placed on UTI prophylaxis, the number of symptomatic UTIs
occurring in their final year of follow-up was recorded based on the number of times
patients complained of UTI symptoms including cloudy/malodorous urine, increased
incontinence, fever, chills and bladder spasms. Where available the number of positive
cultures was also recorded. All cultures were done only after subjects complained of UTI
symptoms and were considered positive when subjects had greater than 103 colony
forming units (cfu)/ml of ≥ 1 organism.

b) Regarding the use of renal ultrasonography rather than regular urodynamic testing as
a routine surveillance method in spinal cord injury patients, data was extracted from
subjects identified in specific objective (a) who met further inclusion and exclusion
criteria.
Subjects included in this objective had received initial urodynamic testing to guide their
pharmacologic and catheterization regimen. After a safe system had been established,
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tracts and bladder to monitor urinary tract stability. Urodynamic testing was repeated
only when patients presented with new symptoms such as persistent urinary tract
infections, increased leakage between catheterization, or with abnormal findings on
ultrasonography.
Data was gathered retrospectively from the medical records of 48 subjects (40 males
and 8 females) who were included in the study. The inclusion criteria were: NB
secondary to SCI; a minimum of one year follow-up at our institution; NB management
with IC; and annual upper tract surveillance with retroperitoneal ultrasound. The primary
endpoint was the presence or absence of abnormal ultrasound findings at the time of last
renal tract surveillance. Specifically the finding of hydronephrosis/pelvicaliectasis,
renal/ureteral calculi, and renal cortical scarring/thinning were noted. The duration of
ultrasound follow-up, degree of disability, and baseline ultrasound and urodynamic
findings were also noted.

c) In order to report our institutional experience with the lowsley retractor method for
suprapubic cystostomy, cases were evaluated as follows:
Subjects were selected from patients undergoing suprapubic cystostomy by one surgeon
at the Yale Urology Medical Group. A search of the billing department database was
conducted with the procedure code for “cystostomy.” A list of 90 patients was generated
and the medical records of these patients were retrospectively reviewed. Patients with
neurogenic bladder, who underwent elective suprapubic cystostomy using the lowsley
retractor method between the years 1995 and 2010 were included. Patients who
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gender of subjects as well as the indication, anesthesia type, catheter size, blood loss,
fluids administered, complications and duration of the procedure were recorded.

Statistical Analysis
All analyses were done with SPSS statistics version 17.0. For comparisons of the mean
age in males and females the student’s t-test was used. Data were represented as counts
and percentages for categorical variables. Means and standard deviations were used for
continuous variables. P < 0.05 was considered statistically significant.

- 18 RESULTS
a) Of 210 SCI patients with neurogenic bladder only 61 subjects, (51 males and 10
females met the inclusion criteria for specific objective (a).
The mean age of the 61 subjects was 43.4 years (16.3) (range: 12-86 years). The age
were similar for male and female subjects; 43.5years (16.5) and 43.2 years (15.5)
respectively. The mean duration of follow-up for all subjects was 5.8 years ( 4.1)
(range: 1-16 years). 18 (30%) subjects were quadriplegic, 35 (57%) were paraplegic and
8 (13%) subjects were fully independent; having neurogenic bladder with preserved
upper and lower limb functions (Table 1).
Figure 1 illustrates the proportion of male, female and all subjects requiring
prophylaxis at the time of last follow-up.

Figure 1. Subjects on PRx by Gender. Bar graph illustrates number of subjects on UTI
prophylaxis by gender and by total number of subjects. +PRx = subjects using
prophylaxis; -PRX = Subjects not using prophylaxis; UTI = urinary tract infection
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demonstrate that 28 (72%) were started on PRx within 2 years after initiation of CIC
(Figure 2). The mean duration of follow-up for subjects on PRx as well as for those not
using PRx are provided in Table 1. The date of initial catheter use was noted in 18 of the
20 (90%) subjects not requiring PRx.

Figure 2. Subjects on PRx by years after starting CIC. Bar graph illustrates number of
subjects started on UTI prophylaxis based on the number of years after starting CIC. CIC
= clean intermittent catheterization; PRx = prophylaxis; UTI = urinary tract infection.

Table 2 lists the number and percentage of subjects on UTI PRx with the number
of positive cultures, ≥ 103 cfu/ml, available within the year prior to starting them on PRx.
Culture results were not available for 11 (27%) of these subjects. Of the 20 subjects not
placed on UTI PRx, 15 had no complaints of UTI symptoms in the final year of follow.
The remaining 5 subjects were each noted to have had only one complaint of
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Culture results were not available for the other 2 subjects.

Table 2. Culture Results for Subjects on UTI PRx
Cx ≥ 103 cfu
n (%)
≥3
17 (41)
2
7 (17)
1
6 (15)
Cx = cultures; cfu = colony forming units; UTI =
urinary tract infection; PRx = prophylaxis.

b) Of the spinal cord injury patients identified in specific objective (a), 48 subjects met
criteria for inclusion in the evaluation of renal tract ultrasonography as a long-term
surveillance method.
The mean age of these subjects was 44.8 years (range: 13-84 years) (Table 3).
Included subjects had been followed for a mean duration of 6.8 years (±3.7) (range: 2-16
years). 26 (54%) subjects were paraplegic, 16 (33%) subjects were quadriplegic and 6
(13%) subjects had adequate function of all extremities. On average subjects were
followed with ultrasonography for 5.2 years (±2.6) (range: 1-9 years) and the average
time between the most recent urodynamic testing and the last ultrasound follow-up was
4.8 years (±3.3).
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Age (y)
44.8 (range: 13-84)
Sex (n)
Male
40 (83)
Female
8 (17)
Injury level (n)
Cervical
22 (46)
Thoracic
16 (33)
Lumbar
10 (21)
Disability (n)
Paraplegia
26 (54)
Quadriplegia
16 (33)
Independent
6 (13)
Duration of follow-up (y)
6.8 (±3.7)
Duration of U/S follow-up (y)
5.2 (±2.6)
Data presented as mean SD, unless noted otherwise;
data in parentheses are percentages. U/S = ultrasound.

Table 4 shows the results of the most recent urodynamic testing in 45 (94%) subjects.
Results of recent urodynamic testing were not available for three subjects.

Table 4. Most recent urodynamic findings
DO
36 (80)
DA/DU
9 (20)
Pseudo-DSD
1 (2)
DSD
9 (20)
Decreased bladder compliance
9 (20)
Data presented as counts (n); data in parenthesis are
percentages. DO = detrusor overactivity; DA = detrusor
areflexia; DU = detrusor underactivity; DSD = detrusor
sphincter dyssynergia.

The results of initial and final ultrasonography exams are illustrated in Figure 3. At
the time of initial retroperitoneal ultrasound, a small renal calculus was present in 1 (2%)
subject, 6 (13%) subjects were noted to have cortical scarring and moderate to minimal
hydronephrosis/caliectasis were found in 5 (10%) subjects. 2 of the 5 cases of upper tract
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follow-up exam.
At the time of last follow-up, final ultrasonography demonstrated small renal/ureteral
calculi in 5 (10%) subjects of which one case was stable compared to the initial exam. No
new cases of renal cortical scarring/thinning were noted and 3 cases of scarring were
stable compared to the initial, while the other 3 cases that were previously noted on initial
ultrasound were not reported in the final ultrasound exams.

Figure 3.Comparison of Initial vs Final Ultrasound Findings. Bar graph illustrates the
changes in retroperitoneal ultrasound findings between the initial ultrasound and the
final ultrasound at last follow-up. Hydroneph = hydronephrosis; U/S = ultrasound.

Moderate to minimal hydronephrosis/caliectasis was present in 7 (15%) subjects at
the time of the final surveillance. Of these, 3 cases were stable and 4 (8%) cases were
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were secondary to obstruction by ureteral calculi in 2 cases and by an enlarged prostate in
the third. The three subjects were treated with laser lithotripsy, extra-corporeal
shockwave lithotripsy and finasteride respectively. No cases of severe hydronephrosis
occurred.

c) For suprapubic cystostomy using the lowsley retractor method, 49 elective cases of
primary suprapubic catheter placements were performed on 44 patients with
neurogenic bladder using a curved lowsley retractor. 23 (52.3%) males and
21(47.7%) females underwent the procedure (Table 5).
Table 5. Patient characteristics
Age (Yr)
44.7 (18.0) (range: 18-86)
Sex (n)
Female
21 (47.7)
Male
23 (52.3)
NGB Etiology (n)
Spinal cord injury
29 (65.9)
Multiple sclerosis
9 (20.5)
Cerebral palsy
1 (2.3)
Spina bifida
1 (2.3)
Spinocereballar ataxia
1 (2.3)
Amytropic lateral sclerosis
1 (2.3)
Parkinson’s disease
1 (2.3)
Anticholinergic side effect
1 (2.3)
Data presented as mean  SD, unless noted otherwise; data in
parentheses are percentages. NGB = neurogenic bladder

The etiology of neurogenic bladder was spinal cord injury in 29 (65.9%) subjects and
multiple sclerosis in 9 (20.5%) subjects. The other 6 (13.6%) patients had neurogenic
bladder from spina bifida, spinocereballar ataxia, cerebral palsy, amyotropic lateral
sclerosis, parkinson’s disease and anticholinergic medication side effect. The mean age
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for males and females, 41.5 years (17.2) and 47.7 years (18.5) respectively, P = 0.23.
8 (16.3%) cases were successfully performed with local and monitored anesthesia
care (Table 6).
Table 6. Operative experience
Anesthesia type (n)
General anesthesia
41 (83.7)
Local + MAC
8 (16.3)
Operation time (min.)
20.2 (5.5) (range: 11-31)
Blood loss
minimal
IV Fluids (mL Crystalloids )
461.2 ( 222.0)
Foley catheter size (Fr)
range: 16-22 Fr
Complications (n)
Hematuria
1 (2.0)
Data presented as mean  SD, unless noted otherwise; data in parentheses are
percentages. MAC = monitored anesthesia care

All other cases were performed under general anesthesia. The mean operation
time documented in 19 (38.7%) cases was 20.2 min (5.5) (range: 11-31 min). Blood
loss was reported as zero or minimal in all cases and records indicate a mean fluid
administration of 461.2 mL crystalloids (222.0) in 31 (63.3%) cases. The median
catheter size inserted was 20-Fr Foley catheter (range: 16-22 Fr). There were no cases of
incorrect catheter placement and no intra-operative complications. One patient returned
with significant hematuria a day following the procedure; Clavian Grade I. No other
minor or major complications were noted.

- 25 DISCUSSION
Urologic advances are credited for the reduced mortality observed in spinal cord
injury patients in recent decades. The improved life expectancy now makes long-term
complications of urinary tract management more pertinent therefore mandating the need
for continued research in this arena. This research retrospectively reports our institutional
outcomes in the long-term management of neurogenic bladder in patients with traumatic
spinal cord injury.
The first objective addressed the association of recurrent urinary tract infections
with the long-term use of CIC in identified spinal cord injury patients followed by the
same physician at the Yale Urology medical group. CIC is a common bladder
catheterization method used in the years following spinal cord injury [50]. Some studies
looking at its efficacy have observed an increased frequency of UTI raising the need for
prophylactic antibiotics [50]. Oral antimicrobials, methenamine compounds and bladder
instillations of providone iodine and chlorhexidine preparations are often used and have
been shown to postpone bacteriuria for short periods in patients managed with CIC [51,
52]. Daily use of low-dose systemic antimicrobials such as trimethoprimsulfamethoxazole has also been shown to be effective in reducing bacteriuria and
symptomatic UTI in persons with acute SCI [53]. The routine use of methenamine
products or systemic antimicrobials for prophylaxis in long-term intermittent
catheterization is controversial and not recommended [22], however in carefully selected
subjects with frequent recurrent symptomatic UTIs this may help improve quality of life.
Our results demonstrated that 67% of our subjects were on UTI prophylaxis at the
time of last follow-up (Figure 1). And that most of these patients were started on
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prophylaxis in this case was defined as the use of oral antimicrobials or methenamine
combined with ascorbic acid. In an acidic environment methenamine forms formic acid
which serves as a bladder antiseptic. Ascorbic acid is used to lower the urine pH
sufficiently for generation of formic acid. Theoretically the combination is effective in
reducing UTI without leading to antibiotic resistance.
Our patients were placed on prophylaxis only after they complained of three or
more episodes of symptomatic UTIs within a one year period and where available, urine
culture results were used to confirm the need of PRx in those subjects using PRx. The
diagnosis of UTI is usually based on the quantification of uropathogens in voided urine,
with significant bacteriuria defined as the amount of uropathogens in urine which
distinguishes true infection or colonization of the urinary tract from contamination [54].
The National Institute on Disability and Rehabilitation Research (NIDRR) defines UTI
by the presence of significant bacteriuria with tissue invasion and resultant tissue
response with signs and/or symptoms of UTI [55]. The criteria for significant bacteriuria
in SCI patients are dependent on the method of bladder management being used. To be
diagnosed with catheter associated UTI, patients managed with intermittent
catheterization require ≥ 103 cfu/ml in addition to UTI symptoms un-attributable to other
sources [56]. This cut-off for positive cultures was used to confirm the need for PRx in
the subjects included in this study.
Urine culture results were found for 31 of 41 (76%) subjects placed on PRx
however culture results were not available for those subjects that were started on PRx at
initial follow-up after they have been referred to our institution for management of
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subjects since patients are often treated outside the purviews of our office with cultures
done by their primary care providers. Of all subjects included in the study, 17 had at
least three positive cultures within the year prior to starting UTI PRx confirming that at
least 28% of our SCI patients were experiencing recurrent symptomatic UTI. These
results suggest that symptomatic UTIs remain a frequent, recurrent complication of clean
intermittent catheterization.
Due to the small number of females included in our study we could not determine
whether the difference in the percentage of male and female subjects requiring UTI PRx
was statistically significant. The issue of sex as an independent risk factor for UTI in SCI
patients remains unresolved. It is well known however that females have a higher
incidence of UTI compared to males in otherwise healthy individuals with normal
bladder function. Since females represent a minority of those with spinal cord injury only
a few studies have compared complication outcomes in male and female SCI patients.
Waites and colleagues did not find sex to be an independent risk factor for UTI in a
prospective study of 61 SCI patients [57]. However a comparative study by Bennett and
associates demonstrated a higher incidence of UTI in females, especially with bowel
organisms [58, 59]. Another study of 302 SCI patients on CIC found a significantly
higher rate of clinical UTI in women even though men and women had equal rates of
bacteriuria [60].
Most of our patients on UTI PRx required it within 2 years of initiating bladder
management with CIC. However, the 20 patients not placed on UTI PRx had been
followed for a mean of 7 years without the need for PRx. These results suggests that
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while those not needing PRx could go on without PRx almost indefinitely. Future studies
will be needed to address what factors influence why certain patients do not experience
frequent recurrent UTI while undergoing long-term bladder management with CIC.
The finding that 67% of our SCI patients are placed on PRx within 2 years of
starting CIC is high and may not be generalizable to the average SCI population since
patients are often referred to our institution for management because they have been
experiencing frequent symptomatic infections. Previous studies have reported that up to
eighty to ninety percent of persons with acute SCI have bacteriuria within 2 to 3 weeks of
starting intermittent catheterization [53]. Esclarin and colleagues found an incidence of
2.75 episodes of bacteriuria/100 Person-days, with 0.41 episodes/100 person-days
incidence for UTI in a retrospective study of adults with acute SCI [61]. Unlike previous
reports, our study investigates the association of symptomatic UTI with long-term CIC in
stable rather than acute SCI. Our results demonstrate that recurrent UTI remains a major
complication of long-term bladder management with clean intermittent catheterization.
An increased incidence of symptomatic UTI has been reported when CIC is performed at
home by a caregiver rather than by the person with SCI [62]. However most of the factors
contributing the increased risk of UTI in patients with CIC remain controversial and
future studies are needed to fully define the risk factors.
The second specific objective evaluated the efficacy of retroperitoneal
ultrasonography as a long-term surveillance method in injured patients managed with
CIC. All patients included in this study were managed with CIC and the results of their
most recent video urodynamics revealed detrusor overactivity in 80%, detrusor sphincter
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included. The standard first line therapy in patients with neurogenic detrusor overactivity
is intermittent catheterization along with oral anticholinergic treatment for detrusor
relaxation [63] because upper tract dilation is caused by a poorly compliant bladder with
high pressure whether or not vesicoureteral reflux is present [64]. Consequent
hydroureteronephrosis in neurogenic bladder patients may cause renal deterioration, renal
failure and death [65].
Study subjects with detrusor overactivity who reported having incontinence or
those with inadequate storage pressures were managed initially with oral anticholinergic
medications to suppress the involuntary contractions, prevent urinary incontinence and
protect the kidneys from high pressures. Urodynamic testing was repeated if patients
presented with new symptoms including recurrent urinary tract infections, incontinence
or increased frequency of catheterization and their management regimen was modified.
Modifications to management strategies in study subjects included optimization of
anticholinergic medication dose, addition of another anticholinergic such as imipramine
or surgical intervention with augmentation cystoplasty.
We retrospectively assessed our population of spinal cord injury patients with
neurogenic bladder for the long-term results of a management regime based on annual
ultrasonography. Urodynamics were repeated only after patients presented either with
new symptoms or with abnormal findings on ultrasonography. Our series demonstrated
that compared to initial ultrasonography, by the time of last follow-up there were 4 (8%)
new cases of moderate or minimal hydronephrosis/caliectasis and 4 (8%) new cases of
small renal/ureteral calculi. 3 of the 4 cases of upper tract dilation however was

- 30 secondary to distal obstruction from calculi and prostatic hyperplasia and no cases
required modification of the bladder management regime. Furthermore, no cases of
severe upper tract dilatation or large stone burden were observed in any of our patients.
All cases of upper tract dilation noted on initial ultrasonography had either resolved or
remained stable by the time of last follow-up after initial management was modified
either by increasing the dosage of anticholinergics or after augmentation cystoplasty was
performed.
Patients managed on an annual urodynamics based regime by Nossseir and
colleagues had no cases of upper tract damage; their series included 51 patients managed
with intermittent catheterization and anticholinergic pharmacotherapy [49]. Although a
significant number of their patients, 10 (20%), suffered from recurrent urinary tract
infections renal ultrasound demonstrated morphologically unaffected upper urinary tract
in all patients. In our series however patients were followed with annual ultrasonography
rather than urodynamics and 8% of our subjects developed mild cases of upper tract
dilation. Most of these cases however were early manifestations of acute obstructive
processes rather than late manifestations of inadequate bladder pressures. And it is
unlikely that a more frequent bladder surveillance regime would have prevented the
development of minimal caliectasis in these subjects.
We propose that after the initial treatment regime is implemented and a safe
system is established, SCI patients managed with intermittent catheterization can be
monitored regularly with retroperitoneal ultrasound alone; and further urodynamic testing
reserved only for patients presenting with new symptoms, to prevent long-term upper
tract damage. Our results demonstrate that bladder management based on annual
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of SCI patients and future studies are needed to demonstrate the frequency of surveillance
necessary to maintain upper tract function in the general SCI population managed with
intermittent catheterization.
Since neurogenic bladder (NGB) patients have been shown to be at increased risk
of injury during suprapubic catheter placement, the third specific objective described our
experience with a safe technique for suprapubic cystostomy (SPC) known as the lowsley
retractor method. Suprapubic cystostomy is used to manage patients in acute urinary
retention, those undergoing lower urinary tract operations as well as persons with
neurogenic bladder.

Various percutaneous and minimally invasive methods for

suprapubic cystostomy have been described but the open approach under general and
spinal anesthesia is still accepted as the definite gold-standard [26]. NGB patients have
been shown to have a higher risk of complication during SPC procedures [27]. Zeidman
and colleagues in 1988 introduced a safe technique for suprapubic catheter placement
using the lowsley retractor designed for perineal prostatectomy [66]. In reporting their
institutional experience they noted no cases of incorrect catheter placement and had no
major or minor complications. However their patient characteristics were not described in
detail and their technique is sometimes avoided for concern of possible urethral injury
and potential difficulty in obese patients [67, 29]. To our knowledge no other institutional
experiences with this approach has been published since its initial introduction. This
report describes our institutional experience with the lowsley retractor method for
isolated primary suprapubic catheter placement in NGB patients.
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patient characteristics or their operative experience. They reported the use of the
procedure in 125 female and 25 male patients needing cystostomy either as an isolated
procedure or as part of a more extensive surgery. They only report the exclusion of male
patients suffering from a fixed pelvic floor after radiation therapy due to difficulty of the
procedure in this group of patients. Their approach was successful in all patients with no
major or minor complications. In this report we describe our experience with the lowsley
retractor method for SPC as an isolated procedure in NGB patients. Our operative
experience regarding operative time, blood loss, and fluids administered are reported in
detail to fully describe the safety and ease of utilizing this technique.
Surgical Technique
Similar to the technique previously described by Zeidman, the patient is placed in dorsal
lithotomy position. A curved lowsley retractor is advanced through the urethral meatus
into the bladder and pointed to the anterior abdominal wall. A small suprapubic incision
is carried through the subcutaneous tissues and the abdominal wall using sharp dissection
or electrocautery until the head of the lowsley retractor is met. The retractor is advanced
through the incision and a 2-0 silk tie is used to tie a Foley catheter (of desired size) to
the head of the lowsley retractor. The catheter is withdrawn into the bladder and out the
urethral meatus using the retractor. The silk tie is cut releasing the end of the Foley
catheter. The catheter is then pulled back through the meatus into the bladder. The
balloon is inflated (10-15 cc), then a rigid cystoscope is introduced into the bladder
confirming appropriate inflation of the catheter within the bladder. The bladder is
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using interrupted 2-0 nylon suture.
The procedure was fast and effective. The operative time was recorded in 19 of
49 cases with a mean of 20.2 minutes (range: 11 – 31 min). All patients had minimal
blood loss and on average required about 500 mL of intravenous crystalloids during the
operation. In the 8 cases where general anesthesia was not used, the patients tolerated the
procedure well under local anesthesia with monitored anesthesia care. There were no
cases of incorrect catheter placements and no intra-operative complications. Our only
complication was in a female spinal cord injury patient who returned to the emergency
department a day following catheter placement with significant hematuria and
hypotension. This complication occurred after her suprapubic catheter was inadvertently
tugged-on at an outpatient care facility. Her hematuria resolved with conservative
management and her pressures normalized after intravenous administration of fluids and
fresh frozen plasma. The lack of other major or minor complications using this technique
is consistent with the outcomes reported by Zeidman in 1988. We did not have any cases
of urethral injury and to our knowledge no cases of urethral injury using the lowsley
retractor method have been published. This suggests that the theoretical risk of possible
urethral injury may be easily avoidable. Also, attempts should be made in future reports
to address outcomes in obese patients undergoing this method of SPC.

CONCLUSION
Although intermittent catheterization is widely viewed as the healthiest bladder
management option, many patients managed with long-term CIC will frequently
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continued need for improvements in bladder management methods to reduce rates of
symptomatic infections in these patients. Future studies are needed to determine the
benefit of UTI prophylaxis in these patients and to address what factors influence why
certain patients managed with long-term CIC continue to experience frequent
symptomatic infections when others do not.
While the combination of CIC and oral anticholinergic therapy is a successful first
line regimen in SCI patients with neurogenic bladder, these patients will often require a
variety of treatment modifications and interventions in long-term follow-up to prevent
upper tract deterioration [41]. This retrospective analysis of patients monitored with
annual retroperitoneal ultrasound rather than regular urodynamics demonstrates that an
ultrasound based surveillance regime is efficacious. Future studies are needed to
determine the optimal surveillance interval with ultrasonography to prevent upper tract
deterioration in spinal cord injury patients managed with clean intermittent
catheterization.
Due to improved pharmacotherapy with anticholinergics, SPC is emerging as an
effective alternative for the long-term management of NGB patients [26]. Patients using
this bladder management method report a high level of satisfaction as well as an
improved quality of life [25]. Various percutaneous procedures have been demonstrated
for suprapubic catheter placements, but patients with NGB have been demonstrated to
have a higher risk of complications following the procedure [27]. This report describes
our experience with SPC using the lowsley retractor method introduced by Zeidman et al.
in 1988. Our findings demonstrate that the technique is easy and safe for performing

- 35 primary cystostomy as an isolated ambulatory procedure in patients with neurogenic
bladder.
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